Oncology News

• ESMO 2021 BrighTNess Follow-Up Data Shed Light on TNBC Therapy Patients with triple negative breast cancer had improved event-free survival when carboplatin (but not the PARP inhibitor veliparib) was added to standard neoadjuvant chemotherapy.
  Medscape Medical News, September 18, 2021
• Pfizer Expands Recall of Antismoking Drug to Include All Lots Ongoing concerns over a nitrosamine impurity in Chantix prompt Pfizer to recall all batches of the product in the United States as a precautionary measure.
  Medscape Medical News, September 17, 2021
• ESMO 2021 Nivo/Ipi Combo Now 'Standard of Care' in Mesothelioma Patients with malignant pleural mesothelioma have a marked and sustained overall survival benefit with nivolumab and ipilimumab vs chemotherapy, even if they discontinue treatment.
  Medscape Medical News, September 17, 2021
• Alert Flurry of Cancer Drug Endorsements From EU Panel The European Medicines Agency panel recommended for approval three new cancer drugs and additional indications for two other already marketed immunotherapies.
  International Approvals, September 17, 2021
• WCLC 2021 Improved Survival in Patients With NSCLC and Brain Metastases About a third of the patients with NSCLC and brain metastases treated with atezolizumab in combination with chemotherapy had overall survival improved to 2 years.
  Medscape Medical News, September 17, 2021
• WCLC 2021 'Urgent' Need to Understand Immunotherapy De-escalation in NSCLC The strong and durable response to immunotherapy in some patients suggests treatment could be reduced or withdrawn, but questions surround which patients will be ideal candidates, an expert argues.
  Medscape Medical News, September 17, 2021
• HPV Vaccine Safety Concerns Up 80% From 2015 to 2018 But adverse events after HPV vaccination actually decreased during the same period, researchers found.
  Medscape Medical News, September 17, 2021
• New Data Show COVID Telehealth Pivot by Patients, Physicians Psychiatrists, dermatologists, urologists, and primary care physicians were among the highest users of teleconferencing for patient visits 6 months after the start of pandemic, according to data.
  Medscape Medical News, September 17, 2021
• Leading Oncologist Overrode Patient's ITU Wishes, Tribunal Hears Professor Justin Stebbing's hearing is continuing in Manchester, UK.
  Medscape News UK, September 17, 2021
• WCLC 2021 Tackling Grief, Loss in Patients With Advanced Lung Cancer Managing distress in patients with a life-limiting condition is challenging, but physicians have a host of strategies at their fingertips to help provide relief, according to palliative care experts.
  Medscape Medical News, September 16, 2021
• Alert FDA Approves First Oral Drug for NSCLC With EGFR Exon20 Insertion The FDA has granted an accelerated approval to mobocertinib for the treatment of locally advanced or metastatic nonsmall cell lung cancer with a specific type of EGFR mutation.
  FDA Approvals, September 16, 2021
• Patients Panic as Docs Cut Off Breast Cancer Drug Many women who have difficult-to-treat metastatic breast cancer and who have positively responded to atezolizumab suddenly had their prescription discontinued.
  Medscape Medical News, September 16, 2021
• Immunotherapy for Cancer Patients With Poor PS Needs a Rethink Use of check point inhibitors for patients with advanced cancer who have poor performance status (PS) needs a rethink, says editorialists.
  Medscape Medical News, September 16, 2021
• Expert Witness 'Unaware' Accused Oncologist Joined Company He Chaired Professor Justin Stebbing's hearing is continuing in Manchester, UK.
  Medscape News UK, September 16, 2021
• US Seniors' Pandemic Care Worst Among Wealthy Nations: Survey Older adults in the US also report pandemic-related economic difficulties at a rate of up to six times that of other countries.
  Medscape Medical News, September 15, 2021
• Alert FDA Grants Zanubrutinib an Accelerated Approval in MZL The US Food and Drug Administration has granted an accelerated approval to zanubrutinib for the treatment of adult patients with relapsed or refractory marginal zone lymphoma.
  FDA Approvals, September 15, 2021
• Researchers Warn Young Adults Are at Highest Risk of Obesity Adults aged 18-24 gained the most weight over 10 years compared with older individuals and should be a key target for prevention programs, say researchers.
  Medscape Medical News, September 15, 2021
• New Tool Better Predicts Subsequent Cancers in Child Survivors An eHealth cancer predisposition screening tool greatly increases the odds of predicting subsequent malignancies in childhood cancer survivors.
  Medscape Medical News, September 15, 2021
• Severe Skin Reactions With Enfortumab Vedotin Approved for metastatic urothelial cancer, the drug has now been associated with cases of severe skins reactions, some of which have been fatal.
  Medscape Medical News, September 15, 2021
• Expert Witness' 'Regrets' Over Letter Supporting Accused Oncologist Professor Justin Stebbing's hearing is continuing in Manchester, UK.
  Medscape News UK, September 15, 2021